Seegene, Inc. (096530.KQ)

22,350.00 +200.00 (+0.90%) 收市：03:30PM KST

Seegene, Inc.

Taewon Building
91 Ogeum-ro Songpa-gu
Seoul 05548
South Korea
82 2 2240 4000
https://www.seegene.com

版塊: 
行業: 
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Jong-Yoon Chun	Founder, CEO, CTO & Director	無	無	1957
Jong-Gi Cheon	Vice President and Chairman of Seegene Medical Foundation	無	無	1962
Mr. Jin-Soo Choi	Executive VP & Director	無	無	1952
Dr. Richard S. Creager Ph.D.	CEO of Seegene Technologies	無	無	1953

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 KRW。

描述

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

公司管治

截至 2024年5月1日 止，Seegene, Inc. 的 ISS 管治質素評分為 10。 Pillar 分數正在審核中：1；董事會：10；股東權利：7；現金賠償：9。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。